Sort by
Refine Your Search
-
Analytical Technology for Biopharmaceutical Process and Product Characterization NIST only participates in the February and August reviews. Biopharmaceuticals are protein-based therapeutics produced
-
the development of analytical methodologies, from both instrumentation and informatics standpoints, for the multifaceted and convoluted data that are obtained from complex biological, chemical, and forensic samples
-
RAP opportunity at National Institute of Standards and Technology NIST Differentiation of Analytical and Biological Variability in Metabolomics using Standard Reference Materials and
-
NIST only participates in the February and August reviews. This research opportunity is focused on developing advanced chemical characterization and analytical chemistry tools, data and research
-
significantly expanding metabolome coverage; however, the complexity of the metabolome still poses significant analytical challenges. Additionally, analytical data from instrumental platforms can be more variable
-
NIST only participates in the February and August reviews. This suite of projects seeks to advance the microbial metabolomics infrastructure through the development of new analytical methods
-
RAP opportunity at National Institute of Standards and Technology NIST Benchmarking metaproteomic analytical workflows Location Material Measurement Laboratory, Chemical Sciences Division
-
involving an actual or planned nuclear attack. Conclusions drawn from this collected data coupled with law enforcement and intelligence information may support attribution—the identification of those
-
the rigorous data quality metrics for accurate diagnostics, prognostics, medical biomarkers, and for untangling the mechanisms of disease. The development and delivery of solution-enabling metrology tools
-
@nist.gov 301 975 2093 Description This opportunity focuses on the development of analytical methods and/or data processing techniques that could be used to advance drug detection and identification (or drug